kstevens@cooley.com
Katie Stevens practices general corporate and securities law, with an emphasis on the representation of emerging companies, public companies and venture capital funds.
Download full bio
Snowflake – $4 Billion IPO
Pulmonx – $218.5 Million IPO
Vaxcyte - $288 Million IPO
Health Catalyst - $209 Million IPO
Emerging Companies
Capital Markets
Venture Capital
Northwestern University Pritzker School of LawJD, cum laude, 2018
Northwestern UniversityBA, Religious Studies with honors, Theta Alpha Kappa, 2012
California
Pulmonx – $218.5 Million IPO October 13, 2020
+1 650 843 5842
Locations